Kate Hsu

Dr. Kate Hsu

MacKay Memorial Hospital, Taipei, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2004 in Molecular Cell
Verified
Journal Article
Closed access
KHKate Hsu
Kate Hsu
JSJegatheesan Seharaseyon
Jegatheesan Seharaseyon
PDPeihong Dong
Peihong Dong
SBStephan Bour
Stephan Bour
EMEduardo Marbán
Eduardo Marbán

17 January 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MCMing-Chin Chang
Ming-Chin Chang
HCHung-I Cheng
Hung-I Cheng
KHKate Hsu
Kate Hsu
YHYen-Ning Hsu
Yen-Ning Hsu
CKChen-Wei Kao
Chen-Wei Kao
CCCaleb Gonshen Chen
Caleb Gonshen Chen
Chronic myeloid leukemia (CML) is a hematological malignancy characterized by the presence of t(9;22) chromosomal translocation that results in BCR-ABL fusion gene. ABL tyrosine kinase inhibitors (TKIs), such as imatinib, nilotinib, and dasatinib, are currently the front-line treatment options for CML. Recently, natural killer (NK) cell activation and expansion have been shown to be associated with optimal treatment responses for CML. To investigate the effects and mechanisms of these TKIs on NK cells, here we characterized activating and inhibitory NK receptors in CD3−CD16+CD56dim NK cells isolated from CML patients in chronic phase (CP). The expressions of activating NK receptors, such as NKG2D, natural cytotoxicity receptor (NCR) and DNAM-1, rebounded after successful TKI treatments for CML. In contrast, among the three surveyed inhibitory receptors (NKG2A, KIR2DL1, and KIR3DL1), only the expression of NKG2A was reverted and suppressed to a very low level by dasatinib, and not by imatinib or nilotinib. CML patients treated with dasatinib indeed expressed fewer NKG2A+ NK cells, which send negative signals for induction of NK cytotoxicity. For these dasatinib-treated patients, the duration to reach major molecular response (MMR) was shorter, and significantly correlated with individual's NKG2A+ NK cell number. This clinical relevance to NKG2A was not observed in treatments with imatinib or nilotinib. In line with dasatinib-specific down-regulation of NKG2A, NK cytotoxicity evaluated by the killing assay was also significantly higher in patients treated with dasatinib than in those treated with imatinib or nilotinib. The lower NK cytotoxicity from imatinib or nilotinib treatments could be reverted by NKG2A blockade using anti-NKG2A antibody. Further in vitro experiments revealed mechanistically that dasatinib could inactivate p38 mitogen-activated protein kinase (MAPK), and consequently affect nuclear import of GATA-3 and GATA-3 transcriptional activities for NKG2A. Our results highlight the dual effects of dasatinib in direct inhibition of ABL kinase and in immunomodulation through NKG2A down-regulation, contributing to accelerated molecular responses (MR) in CML.

1 September 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
Ken-Hong LimKen-Hong Lim
Ken-Hong Lim
LCLih-Chyang Chen
Lih-Chyang Chen
KHKate Hsu
Kate Hsu
Chia-Ching ChangChia-Ching Chang
Chia-Ching Chang
CCChia-Yu Chang
Chia-Yu Chang
CCCaleb Gonshen Chen
Caleb Gonshen Chen
BAFF supports B-cell survival and homeostasis by activating the NF-κB pathway. While NF-κB is also involved in the priming signal of NLRP3 inflammasome, the role of BAFF in NLRP3 inflammasome regulation is unknown. Here we report BAFF engagement to BAFF receptor elicited both priming and activating signals for NLRP3 inflammasomes in primary B cells and B lymphoma cell lines. This induction of NLRP3 inflammasomes by BAFF led to increased NLRP3 and IL-1β expression, caspase-1 activation, IL-1β secretion, and pyroptosis. Mechanistically, BAFF activated NLRP3 inflammasomes by promoting the association of cIAP-TRAF2 with components of NLRP3 inflammasomes, and by inducing Src activity-dependent ROS production and potassium ion efflux. B-cell receptor (BCR) stimulation on the Lyn signaling pathway inhibited BAFF-induced Src activities and attenuated BAFF-induced NLRP3 inflammasome activation. These findings reveal an additional function of BAFF in B-cell homeostasis that is associated with BCR activities.

1 September 2010 in Biophysical Journal
Verified
Journal Article
Closed access
KHKate Hsu
Kate Hsu
JHJin Han
Jin Han
KSKrekwit Shinlapawittayatorn
Krekwit Shinlapawittayatorn
IDIsabelle Deschenes
Isabelle Deschenes
EMEduardo Marbán
Eduardo Marbán

30 July 2001 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
TYToshio Yamagishi
Toshio Yamagishi
RLRonald A. Li
Ronald A. Li
KHKate Hsu
Kate Hsu
EMEduardo Marbán
Eduardo Marbán
GTGordon F. Tomaselli
Gordon F. Tomaselli
The permeation pathway of the Na channel is formed by asymmetric loops (P segments) contributed by each of the four domains of the protein. In contrast to the analogous region of K channels, previously we (Yamagishi, T., M. Janecki, E. Marban, and G. Tomaselli. 1997. Biophys. J. 73:195–204) have shown that the P segments do not span the selectivity region, that is, they are accessible only from the extracellular surface. The portion of the P-segment NH2-terminal to the selectivity region is referred to as SS1. To explore further the topology and functional role of the SS1 region, 40 amino acids NH2-terminal to the selectivity ring (10 in each of the P segments) of the rat skeletal muscle Na channel were substituted by cysteine and expressed in tsA-201 cells. Selected mutants in each domain could be blocked with high affinity by externally applied Cd2+ and were resistant to tetrodotoxin as compared with the wild-type channel. None of the externally applied sulfhydryl-specific methanethiosulfonate reagents modified the current through any of the mutant channels. Both R395C and R750C altered ionic selectivity, producing significant increases in K+ and NH4+ currents. The pattern of side chain accessibility is consistent with a pore helix like that observed in the crystal structure of the bacterial K channel, KcsA. Structure prediction of the Na channel using the program PHDhtm suggests an α helix in the SS1 region of each domain channel. We conclude that each of the P segments undergoes a hairpin turn in the permeation pathway, such that amino acids on both sides of the putative selectivity filter line the outer mouth of the pore. Evolutionary conservation of the pore helix motif from bacterial K channels to mammalian Na channels identifies this structure as a critical feature in the architecture of ion selective pores.

27 August 2009 in Blood
Verified
Journal Article
Closed access
PDF file
KHKate Hsu
Kate Hsu
NCNaiwen Chi
Naiwen Chi
MGMarjan Gucek
Marjan Gucek
JEJennifer E. Van Eyk
Jennifer E. Van Eyk
RCRobert N. Cole
Robert N. Cole
DFD. Brian Brian Foster
D. Brian Brian Foster
The special blood group antigen Mi.III exhibits a characteristic hybrid structure of glycophorin A (GPA) and glycophorin B, termed Gp.Mur. This phenotype has exceptionally high occurrence rates in several indigenous tribes in Taiwan (∼21.2%-88.4%). Because glycophorin/Miltenberger begins interaction with anion exchanger-1 (AE1) in the endoplasmic reticulum, we hypothesized that the AE1-based macrocomplexes on erythrocyte membranes obtained from Mi.III+ people could be differentiated from those obtained from non-Miltenberger people. Quantitative mass spectrometric comparison of the AE1-based complexes by iTRAQ™ (Applied Biosystems) revealed 25% to 67% higher expression of AE1 in Mi.III+ erythrocytes. In accordance with the higher AE1 level, the Mi.III+ erythrocytes exhibited superior HCO3− capacities, pH homeostasis, and osmotic resistance. Cotransfection experiments in HEK293 cells showed that Gp.Mur, like GPA, enhanced trafficking of AE1 to the plasma membrane. In summary, the increased surface expression of AE1 in Mi.III+ erythrocytes could be attributed to the additive effect of GPA and Gp.Mur coexpression.